SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $12,977,000 | -23.4% | 92,500 | 0.0% | 0.52% | -15.7% |
| Q2 2019 | $16,936,000 | +15.1% | 92,500 | 0.0% | 0.61% | +8.1% |
| Q1 2019 | $14,712,000 | +213.4% | 92,500 | +88.8% | 0.57% | +155.4% |
| Q4 2018 | $4,694,000 | -32.2% | 49,000 | 0.0% | 0.22% | -11.6% |
| Q3 2018 | $6,921,000 | -9.8% | 49,000 | 0.0% | 0.25% | -14.9% |
| Q2 2018 | $7,670,000 | -2.8% | 49,000 | 0.0% | 0.30% | -12.5% |
| Q1 2018 | $7,892,000 | +6.5% | 49,000 | +8.9% | 0.34% | +0.3% |
| Q4 2017 | $7,412,000 | +266.0% | 45,000 | +38.5% | 0.34% | +261.3% |
| Q3 2017 | $2,025,000 | – | 32,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |